December 21, 2006 Public Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006In this Infomail, Dr. David Cohen, AHRP Secretary gives his brief personal impressions from the December 13 Read More Public Testimonies at FDA-SSRI-Suicidality Hearings, Dec. 13, 2006
December 20, 2006 Blood substitute`a disaster’ in trial Northfield still plans toseek FDA approvalThe wholly unethical artificial blood experiment was conducted on non-consenting trauma patients. The Chicago Tribune reports: "In Read More Blood substitute`a disaster’ in trial Northfield still plans toseek FDA approval
December 20, 2006 Houston TX – Drug Makers Accused Of Misleading Health Dept_ KEYE-TV The suit by Allen Jones, formerly assistant Inspector General in Pennsylvania, and the Texas Attorney General charges Read More Houston TX – Drug Makers Accused Of Misleading Health Dept_ KEYE-TV
December 20, 2006 Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearingsThe New York Times reports (below) that a federal court overseeing Zyprexa litigation has ordered Jim Gottstein Read More Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings
December 19, 2006 “Big Bucks, Big Pharma” Video documentaryA 5 minute video documentary, "Big Bucks, Big Pharma," posted on Google by Media Education Information, focuses Read More “Big Bucks, Big Pharma” Video documentary
December 19, 2006 Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label UseThe New York Times reports (below) that additional state Attorneys General are demanding that Eli "Lilly hand Read More Lilly Marketing Zyprexa Challenged by Stat AGs–NYT_Antipsychotics: Off-label Use
December 19, 2006 Documents Show Eli Lilly Lied about ZyprexaNoting the documented evidence spelled out in Alex Berenson's report aboutthe revelations contained in Eli Lilly's secret Read More Documents Show Eli Lilly Lied about Zyprexa
December 18, 2006 AHRQ No Evidence to Support Off-Label Uses of Atypical AntipsychoticsA new federally funded study by HHS Agency for Healthcare Research andQuality, found little or no evidence Read More AHRQ No Evidence to Support Off-Label Uses of Atypical Antipsychotics
December 18, 2006 Thinking Can Change the brainBelow are excerpts selected by Sharon Begley, Wall Street Journal science columnist, from her own book, “Train Read More Thinking Can Change the brain
December 18, 2006 Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearingsThe Times notes the documented evidence spelled out in Alex Berenson's report aboutthe revelations contained in Eli Read More Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings
December 18, 2006 Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYTFederal law prohibits drug companies from promoting drugs for uses unapproved by the FDA. Zyprexa (olanzapine) is Read More Company Documents Show Eli Lilly Promoted Zyprexa for Unapproved Use_NYT
December 17, 2006 DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USETHE NEW YORK TIMES DRUG FILES SHOW MAKER PROMOTED UNAPPROVED USE December 18, 2006 By ALEX BERENSON Read More DRUG FILES SHOW LILLY PROMOTED ZYPREXA FOR UNAPPROVED USE
December 17, 2006 Two Days in in U.S. Federal District Court Re: Lilly Zyprexa DocumentsThe legal battle over Eli Lilly's Zyprexa documents–which were released to The New York Times in December,2006–was Read More Two Days in in U.S. Federal District Court Re: Lilly Zyprexa Documents
December 17, 2006 Eli Lilly Documents Show Risks of Zyprexa were deliberately played down_NYTYesterday, we reported about a whistleblower's lawsuit against Johnson & Johnson to which the Texas Attorney General has Read More Eli Lilly Documents Show Risks of Zyprexa were deliberately played down_NYT